Fully competent dendritic cells as inducers of T cell anergy in autoimmunity

Por Quaratino, S, Duddy, LP, Londei, M
Publicado em 2001

Fully competent dendritic cells as inducers of T cell anergy in autoimmunity

Por Quaratino, Sonia, Duddy, Linda P., Londei, Marco
Publicado em 2000

Relation between fractional urate excretion and serum triglyceride concentrations.

Por Quaratino, C P, Rucci, C, Giacomello, A
Publicado em 1996

Expression of the identical V beta gene in human T-cell clones does not confer the same pattern of responsiveness to bacterial enterotoxins.

Por Quaratino, S, Verhoef, A, Kahan, M, Londei, M
Publicado em 1993

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells

Por Osman, Mohamed, Tortorella, Micky, Londei, Marco, Quaratino, Sonia
Publicado em 2002

Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry.

Por Quaratino, S, Thorpe, C J, Travers, P J, Londei, M
Publicado em 1995

Anti tumour necrosis-α therapy increases the number of FOXP3(+) regulatory T cells in children affected by Crohn's disease

Por Ricciardelli, Ida, Lindley, Keith J, Londei, Marco, Quaratino, Sonia
Publicado em 2008

Definition of unique traits of human CD4-CD8- alpha beta T cells.

Por Murison, J G, Quaratino, S, Kahan, M, Verhoef, A, Londei, M
Publicado em 1993

Aminopenicillin allergy

Por Romano, A, Quaratino, D, Papa, G, Di, F, Venuti, A
Publicado em 1997

FAS engagement drives apoptosis of enterocytes of coeliac patients

Por Maiuri, L, Ciacci, C, Raia, V, Vacca, L, Ricciardelli, I, Raimondi, F, Auricchio, S, Quaratino, S, Londei, M
Publicado em 2001

MiR-19-mediated inhibition of Transglutaminase-2 leads to enhanced invasion and metastasis in colorectal cancer

Por Cellura, D, Pickard, K, Quaratino, S, Parker, H, Strefford, JC, Thomas, GJ, Mitter, R, Mirnezami, AH, Peake, NJ
Publicado no Mol Cancer Res (2015)

Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis

Por Raia, V, Maiuri, L, Ciacci, C, Ricciardelli, I, Vacca, L, Auricchio, S, Cimmino, M, Cavaliere, M, Nardone, M, Cesaro, A, Malcolm, J, Quaratino, S, Londei, M
Publicado em 2005

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

Por van den Heuvel, Michel M, Verheij, Marcel, Boshuizen, Rogier, Belderbos, José, Dingemans, Anne-Marie C, De Ruysscher, Dirk, Laurent, Julien, Tighe, Robert, Haanen, John, Quaratino, Sonia
Publicado no J Transl Med (2015)

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein

Por Laurent Julien, Touvrey Cedric, Gillessen Silke, Joffraud Magali, Vicari Manuela, Bertrand Caroline, Ongarello Stefano, Liedert Bernd, Gallerani Elisa, Beck Joachim, Omlin Aurelius, Sessa Cristiana, Quaratino Sonia, Stupp Roger, Gnad-Vogt Ulrike S, Speiser Daniel E
Publicado em 2013-01-01

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein

Por Laurent, Julien, Touvrey, Cedric, Gillessen, Silke, Joffraud, Magali, Vicari, Manuela, Bertrand, Caroline, Ongarello, Stefano, Liedert, Bernd, Gallerani, Elisa, Beck, Joachim, Omlin, Aurelius, Sessa, Cristiana, Quaratino, Sonia, Stupp, Roger, Gnad-Vogt, Ulrike S, Speiser, Daniel E
Publicado em 2013